Aristides Capital’s Evolus EOLS Stock Holding History

Aristides Capital’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-32,004	Closed	-$208K	–	218
2021 Q4	$208K	Buy	+32,004	New	+$220K	0.1%	199
2020 Q1	–	Sell	-17,482	Closed	-$213K	–	182
2019 Q4	$213K	Buy	+17,482	New	+$247K	0.17%	150

Other funds holding EOLS

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristides Capital's EOLS Position: Q1 2022 in Review

Aristides Capital sold out of Evolus (EOLS) in Q1 2022, closing a stake of 32,004 shares — an estimated $208K sold.

Aristides Capital first reported a position in EOLS in Q4 2019 and held it in 2 quarters. The position peaked at $213K in Q4 2019. 118 funds tracked by Wall St. Rank hold EOLS as of Q1 2022.

Aristides Capital reported no remaining Evolus position as of Q1 2022 after selling out during the quarter.
Aristides Capital sold 32,004 Evolus shares in Q1 2022, an estimated $208K.
Aristides Capital first reported a position in Evolus in Q4 2019 and held it in 2 quarters.
Aristides Capital's Evolus position peaked at $213K in Q4 2019.
118 funds tracked by Wall St. Rank held Evolus as of Q1 2022.

Based on Aristides Capital's 13F filing for Q1 2022, filed 16 May 2022.